JP2010501483A5 - - Google Patents

Download PDF

Info

Publication number
JP2010501483A5
JP2010501483A5 JP2009524574A JP2009524574A JP2010501483A5 JP 2010501483 A5 JP2010501483 A5 JP 2010501483A5 JP 2009524574 A JP2009524574 A JP 2009524574A JP 2009524574 A JP2009524574 A JP 2009524574A JP 2010501483 A5 JP2010501483 A5 JP 2010501483A5
Authority
JP
Japan
Prior art keywords
imaging agent
imaging
agent according
spectroscopy
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009524574A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010501483A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/NO2007/000287 external-priority patent/WO2008020765A2/en
Publication of JP2010501483A publication Critical patent/JP2010501483A/ja
Publication of JP2010501483A5 publication Critical patent/JP2010501483A5/ja
Withdrawn legal-status Critical Current

Links

JP2009524574A 2006-08-18 2007-08-17 乳酸塩及び過分極13c−ピルビン酸塩を含むイメージング剤 Withdrawn JP2010501483A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20063701 2006-08-18
PCT/NO2007/000287 WO2008020765A2 (en) 2006-08-18 2007-08-17 Imaging medium comprising lactate and hyperpolarised 13c-pyruvate

Publications (2)

Publication Number Publication Date
JP2010501483A JP2010501483A (ja) 2010-01-21
JP2010501483A5 true JP2010501483A5 (enExample) 2010-08-26

Family

ID=38719770

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009524574A Withdrawn JP2010501483A (ja) 2006-08-18 2007-08-17 乳酸塩及び過分極13c−ピルビン酸塩を含むイメージング剤

Country Status (6)

Country Link
US (1) US20100178249A1 (enExample)
EP (1) EP2051739A2 (enExample)
JP (1) JP2010501483A (enExample)
KR (1) KR20090052859A (enExample)
CN (1) CN101505802A (enExample)
WO (1) WO2008020765A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2543704C2 (ru) * 2009-04-02 2015-03-10 ДжиИ ХЕЛТКЕР ЛИМИТЕД Применение магнитно-резонансной визуализирующей среды, содержащей гиперполяризованный 13с-пируват, для обнаружения воспаления или инфекции
KR101690821B1 (ko) 2009-09-10 2016-12-28 지이 헬쓰케어 리미티드 과분극화된 13c-프럭토즈를 사용하는 13c-자기 공명 검출 방법
US9259490B2 (en) 2010-05-03 2016-02-16 Ge Healthcare Limited Hyperpolarized lactate contrast agent for determination of LDH activity
US9452409B2 (en) 2011-04-22 2016-09-27 Vanderbilt University Para-hydrogen polarizer
EP2950826B1 (en) 2013-01-31 2019-09-18 Bracco Imaging S.p.A Hyperpolarized esters as metabolic markers in mri
EP2863229A1 (en) 2013-10-15 2015-04-22 Technische Universität München pH-biosensors based on compounds with pH-sensitive enolic groups for magnetic resonance imaging and spectroscopy and their uses
US20160252532A1 (en) * 2013-10-15 2016-09-01 Technische Universität München pH-Biosensors Based on Compounds Produced From Pyruvic Acid For Magnetic Resonance Imaging and Spectroscopy and Their Uses
KR101516634B1 (ko) * 2014-07-09 2015-05-06 연세대학교 산학협력단 13c-자기공명분광영상을 이용한 암 환자의 치료 예후를 예측하는 방법
US11938200B2 (en) 2016-02-05 2024-03-26 The Trustees Of The University Of Pennsylvania Non-nutritive sweeteners and polyols as imaging agents
US10901058B2 (en) 2016-02-05 2021-01-26 The Trustees Of The University Of Pennsylvania Chemical exchange saturation transfer (CEST) imaging of lactate (LATEST)
KR101939454B1 (ko) * 2017-03-21 2019-01-16 전남대학교산학협력단 생체 내 과분극화 c13 피루베이트 자기공명분광법을 이용하여 새로운 정량적 생체지표를 통한 비알코올성 지방간질환 진단 방법
KR102457806B1 (ko) * 2020-11-02 2022-10-28 전남대학교 산학협력단 과분극화된 13c 피루베이트 자기공명분광영상을 이용한 만성 간질환의 예후 판단을 위한 정보제공방법
WO2024254159A1 (en) * 2023-06-05 2024-12-12 The Regents Of The University Of California Compositions and method for diagnosing and treating alzheimer's disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6329208B1 (en) * 1997-07-16 2001-12-11 Board Of Regents, The University Of Texas System Methods for determining gluconeogenesis, anapleurosis and pyruvate recycling
EP1302465A1 (en) * 2001-10-11 2003-04-16 BRACCO IMAGING S.p.A. Enhanced substrate imaging by reversible binding to a paramagnetic complex
CA2576202A1 (en) * 2004-07-30 2006-02-02 Ge Healthcare As Mr imaging method for the discrimination between healthy and tumour tissue
JP5456256B2 (ja) * 2004-11-19 2014-03-26 ジーイー・ヘルスケア・アクスイェ・セルスカプ 心臓イメージング法
EP1998813A2 (en) * 2006-03-29 2008-12-10 GE Healthcare AS Method to produce hyperpolarised carboxylates and sulphonates in the presence of inorganic cations
JP5363320B2 (ja) * 2006-08-18 2013-12-11 ジーイー・ヘルスケア・アクスイェ・セルスカプ 細胞死の13c−mrイメージング又は分光法

Similar Documents

Publication Publication Date Title
JP2010501483A5 (enExample)
Hu et al. Activatable albumin-photosensitizer nanoassemblies for triple-modal imaging and thermal-modulated photodynamic therapy of cancer
Yang et al. Analysis of hypoxia-induced metabolic reprogramming
Kandhare et al. Ameliorative effects quercetin against impaired motor nerve function, inflammatory mediators and apoptosis in neonatal streptozotocin-induced diabetic neuropathy in rats
Wang et al. Activatable photoacoustic and fluorescent probe of nitric oxide for cellular and in vivo imaging
Zhang et al. Photo-responsive polydopamine nanoenzyme microneedles with oxidative stress regulation ability for atopic dermatitis treatment
Laustsen et al. Insufficient insulin administration to diabetic rats increases substrate utilization and maintains lactate production in the kidney
US20100178249A1 (en) Imaging medium comprising lactate and hyperpolarised 13c-pyruvate
JP2011514313A5 (enExample)
ES2381380T3 (es) Formación de imagenes de 13C-RM o de espectroscopia de muerte celular
Wu et al. A conjugated-polymer-based ratiometric nanoprobe for evaluating in-vivo hepatotoxicity induced by herbal medicine via MSOT imaging
Qi et al. Effects of anesthesia on renal function and metabolism in rats assessed by hyperpolarized MRI
CA2797472A1 (en) Hyperpolarized lactate contrast agent for determination of ldh activity
Kumagai et al. Observation of glycolytic metabolites in tumor cell lysate by using hyperpolarization of deuterated glucose
CN102083470A (zh) 应用超极化13c-丙酮酸盐,通过13c-mr检测测定丙氨酸转氨酶(alt)活性的方法
CN118995212B (zh) 一种细胞核仁靶向红色荧光碳点及其制备方法和应用
Hansen et al. Hyperpolarized 13C MRI reveals large changes in pyruvate metabolism during digestion in snakes
Bala et al. Zebra fish in toxicology research: streptavidin conjugated peroxidase assay in the development phase of zebrafish embryos to study liver toxicities
Huo et al. Delayed diagnosis of glucagonoma syndrome: a case report.
Orfanidou et al. The force of the spontaneously contracting zebrafish heart, in the assessment of cardiovascular toxicity: application on adriamycin
Fan et al. Development of a hemicyanine-based turn-on probe for MAO-A imaging in metabolic disorders in vivo and in serum
Kim et al. Transplacental pharmacokinetics of the new fluoroquinolone DW-116 in pregnant rats
Qu et al. A novel magnetic resonance contrast agent for detection of hepatic segmental function
Kashina et al. Applications of FLIM in regenerative medicine
Ryan Assessing mitochondrial energetics in vivo with molecular detail: the best of both worlds using mitoRACE.